Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans?-Reference-Cited by-同舟云学术

Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans?

Published:1995-01 Issue:1 Volume:66 Page:17-37
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Berendsen H.H.G.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference184 articles.

1. Cloning of another human serotonin receptor (5HTIE) a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase;Adham,1993

2. Blockade and reversal of 5-methoxy-N,N-dimethyltryptamineinduced analgesia following noradrenaline depletion;Archer;Brain Res.,1985

3. Facilitation of 8-OH-DPAT induced forepaw treading of rats by the 5-HT2 agonist DOI;Arnt;Eur. J. Pharmacol.,1989

4. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects;Arora;Am. J. Psychiatry,1989

5. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors;Artigas;Arch. Gen. Psychiatry,1994

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reverse Binding Mode of Phosphotyrosine Peptides with SH2 Protein;Biochemistry;2018-08-09

2. Convergence of glycogen synthase kinase 3β and GR signaling in response to fluoxetine treatment in chronically stressed female and male rats;Behavioural Brain Research;2017-08

3. Gd(III)‐DO3A‐SBMPP: An Effort to Develop the MRI Contrast Agent with Enhanced Relaxivity;ChemistrySelect;2016-11-16

4. Psilocybin for treating substance use disorders?;Expert Review of Neurotherapeutics;2016-08-12

5. The effects of systemic administration and local microinjection into the central nervous system of the selective serotonin 5-HT2C receptor agonist RO-600175 on sleep and wakefulness in the rat;Behavioural Pharmacology;2015-08